MARKET

CSCI

CSCI

Cosciens Biopharma
NASDAQ
3.530
+0.020
+0.57%
After Hours: 3.470 -0.06 -1.70% 16:04 07/11 EDT
OPEN
3.432
PREV CLOSE
3.510
HIGH
3.530
LOW
3.310
VOLUME
3.19K
TURNOVER
--
52 WEEK HIGH
7.54
52 WEEK LOW
1.960
MARKET CAP
11.11M
P/E (TTM)
-0.6088
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CSCI last week (0630-0704)?
Weekly Report · 6d ago
COSCIENS Biopharma Announces Shareholder Meeting Results and Strategic Developments
TipRanks · 06/30 21:54
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders
Barchart · 06/30 17:33
Weekly Report: what happened at CSCI last week (0623-0627)?
Weekly Report · 06/30 10:52
Weekly Report: what happened at CSCI last week (0616-0620)?
Weekly Report · 06/23 10:46
Weekly Report: what happened at CSCI last week (0609-0613)?
Weekly Report · 06/16 10:51
COSCIENS Biopharma Announces Virtual Shareholder Meeting on June 30, 2025
TipRanks · 06/09 21:54
Weekly Report: what happened at CSCI last week (0602-0606)?
Weekly Report · 06/09 10:52
More
About CSCI
COSCIENS Biopharma Inc. is a Canada-based life science company. The Company is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The Company's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

Webull offers COSCIENS Biopharma Inc (USA) stock information, including NASDAQ: CSCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCI stock methods without spending real money on the virtual paper trading platform.